Patrick J. Crutcher 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-27 5:00 pm Unchanged | 2025-08-06 | 13G | Avalo Therapeutics, Inc. AVTX | Patrick J. Crutcher | 549,467 4.200% | 0 (Unchanged) | Filing |
| 2024-11-07 5:00 pm Purchase | 2024-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | Patrick J. Crutcher | 549,467 5.600% | 438,616 (+395.68%) | Filing |
| 2024-08-23 4:05 pm Purchase | 2024-08-13 | 13G | Avalo Therapeutics, Inc. AVTX | Patrick J. Crutcher | 110,851 9.900% | 110,851 (New Position) | Filing |